Dr.Archie Bleyer
Months ago Dr. Hastings invited me to hear Dr. Bleyer speak if she could arrange for him to come to Reno. Her efforts came to fruition and Wednesday night I was able to hear him speak at Rapscallions.(yes, yumm-o) He spoke to a group of doctors, nurses on A.L.L. specifically focusing on adolescents and young adults. I ate up every word he said and found it fascinating. With what is going on around the world concerning advancements in A.L.L. treatment, France is the place to be. Hands down, they are the front runner in this race. Although France does not have an obesity problem like we do here in the states, they are are making great strides in furthering treatments regimes for young adults. (obesity greatly inhibits positive outcomes for patients with leukemia) This is not to say that treatment for patients in the states is inferior, but clearly they are doing amazing things. It is well known that adolescents and young adults, even up to age 40, fair much better being treated on pediatric protocols vs. adult. There is no disputing this when you see the data. He also spoke of certain meds like PEG/aspiriganease, and how they make a difference in cure rates, remissions, etc. He also discussed delayed intensification 1 and delayed intensification 2 and how these phases are vitally important and play a big role in a positive outcome. Kristin has gone through these because of her high risk status. We wish that she did not need to because they were hell and at the same time life saving.
He touched briefly on Kristin's particular genetic expression of leukemia, particularly the t4,11 translocation. Holding my breath, I waited for more information with hopes that I would finally get more answers but, he quickly moved on. I have spent many, many hours researching whatever I could find on this particular subgroup of A.L.L. as it pertains to adolescents. There just is not much out there and our doctors just do not know, or they are just not talking about it. If anyone knew, he would. When it came time for questions, I asked Sandy Payne to speak for me concerning other patients her age with this translocation . (I was a bit nervous amongst all the brainiacs in the room) He gave a good, straight forward answer. I will just say that Kristin is unique and she is boldly setting a new standard. Along with top notch doctors from Children's Hospital Oakland, faith, prayers and blessings, she is getting better and better every day. With each day forward, that means that there is one more day behind, leaving the cancer in the past, and looking forward is where she is going.
read on to see just how amazing Dr. bleyer is....
In the 1980s, Dr. Bleyer served as Professor of Pediatrics, Adjunct Professor of Medicine and Radiation Oncology, and American Cancer Society Professor of Clinical Oncology at the University of Washington, Fred Hutchinson Cancer Research Center, and the Children’s Hospital Regional Medical Center in Seattle.
In the 1990s, Dr. Bleyer was Chair of the world’s largest pediatric cancer research organization and Chair of the Pediatrics Department at the largest cancer center in the world, the M.D. Anderson Cancer Center in Houston, Texas. Before moving to Bend, Dr. Bleyer pioneered the adolescent and young adult (AYA) cancer initiative [3,4], which has become a national program [5] adopted by Canada and countries in Europe and Asia [6]. Dr. Bleyer is also a founding member of the LiveStrong Young Adult Alliance and Chair of its Science Task Force.
Since 1999, Bleyer has been named among America’s Top Doctors, and has been a recipient of American Cancer Society’s Partners in Courage Award, the American Society of Pediatric Hematology/Oncology Distinguished Career Award, and a Fellowship in the Royal College of Physicians and Surgeons (Glasgow, Scotland).
During the past three decades, Dr. Bleyer was awarded research grants totaling more than $75 million as a principal investigator from the National Institutes of Health, the American Cancer Society, and the Leukemia Society of America. His research has been published in more than 300 peer-reviewed articles, chapters, and books.
He touched briefly on Kristin's particular genetic expression of leukemia, particularly the t4,11 translocation. Holding my breath, I waited for more information with hopes that I would finally get more answers but, he quickly moved on. I have spent many, many hours researching whatever I could find on this particular subgroup of A.L.L. as it pertains to adolescents. There just is not much out there and our doctors just do not know, or they are just not talking about it. If anyone knew, he would. When it came time for questions, I asked Sandy Payne to speak for me concerning other patients her age with this translocation . (I was a bit nervous amongst all the brainiacs in the room) He gave a good, straight forward answer. I will just say that Kristin is unique and she is boldly setting a new standard. Along with top notch doctors from Children's Hospital Oakland, faith, prayers and blessings, she is getting better and better every day. With each day forward, that means that there is one more day behind, leaving the cancer in the past, and looking forward is where she is going.
read on to see just how amazing Dr. bleyer is....
In the 1980s, Dr. Bleyer served as Professor of Pediatrics, Adjunct Professor of Medicine and Radiation Oncology, and American Cancer Society Professor of Clinical Oncology at the University of Washington, Fred Hutchinson Cancer Research Center, and the Children’s Hospital Regional Medical Center in Seattle.
In the 1990s, Dr. Bleyer was Chair of the world’s largest pediatric cancer research organization and Chair of the Pediatrics Department at the largest cancer center in the world, the M.D. Anderson Cancer Center in Houston, Texas. Before moving to Bend, Dr. Bleyer pioneered the adolescent and young adult (AYA) cancer initiative [3,4], which has become a national program [5] adopted by Canada and countries in Europe and Asia [6]. Dr. Bleyer is also a founding member of the LiveStrong Young Adult Alliance and Chair of its Science Task Force.
Since 1999, Bleyer has been named among America’s Top Doctors, and has been a recipient of American Cancer Society’s Partners in Courage Award, the American Society of Pediatric Hematology/Oncology Distinguished Career Award, and a Fellowship in the Royal College of Physicians and Surgeons (Glasgow, Scotland).
During the past three decades, Dr. Bleyer was awarded research grants totaling more than $75 million as a principal investigator from the National Institutes of Health, the American Cancer Society, and the Leukemia Society of America. His research has been published in more than 300 peer-reviewed articles, chapters, and books.
+of+fallwinterballoakland+003.jpg)
Comments